Skip to main content

New £42 million screening trial to improve efficacy of prostate cancer screening

Queen Mary’s Professor Rhian Gabe is named as one of six lead researchers in the new £42 million TRANSFORM trial to find the best way to screen for prostate cancer.

Published on:
Back to top